Manufacturer record
Navkar Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Navkar Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between October 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 0F5008A, Sucralfate & Povidone-Iodine Ointment (exp May 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Assay for Available Iodine. Listed in the September 2026 alert.
Records by type
14 records linked to Navkar Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sucralfate & Povidone-Iodine Ointment | Batch 0F5008AMfg Jun 2025 · Exp May 2027 | Assay for Available IodineAssay | DTL, Bengaluru, KarnatakaState lab | Sep 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | Batch L15017AMfg Sep 2025 · Exp Aug 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Sep 2026 |
| Povidone-Iodine Ointment USP | Batch OG5019AMfg Jul 2025 · Exp Jun 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Paracetamol | Batch TF3059AMfg Jun 2023 · Exp May 2026 | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab | Jan 2026 |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Broxin-SB Expectorant) | Batch LA5029AMfg Jan 2025 · Exp Dec 2026 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Dec 2025 |
| Povidone-Iodine Ointment USP | Batch OI4004AMfg Sep 2024 · Exp Aug 2026 | Assay of Povidone Iodine calculated as available IodineAssay | RDTL, ChandigarhCDSCO lab | Mar 2025 |
| Itraconazole Capsules B.P. 100 mg | Batch CH2006AMfg Aug 2022 · Exp Jul 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
| Cuprox-10 (Isoxsuprine Hydrochloride Tablets I.P. 10 mg) | Batch G-153/4014Mfg Sep 2021 · Exp Aug 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2023 |
| Ofloxacin & Ornidazole Tablets IP | Batch TK0034AMfg Nov 2020 · Exp Oct 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jul 2022 |
| Ofloxacin & Ornidazole Tablets IP | Batch TB1030AMfg Feb 2021 · Exp Jan 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2022 |
| Ofloxacin & Ornidazole Tablets IP | Batch TB1045AMfg Feb 2021 · Exp Jan 2023 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Jul 2022 |
| Pantoprazole Gastro-Resistant Tablets IP | Batch TF1037AMfg Jun 2021 · Exp Nov 2022 | DissolutionDissolution | CDTL ChennaiCDSCO lab | May 2022 |
| Pantoprazole Gastro- Resistant Tablets IP | Batch TF1036AMfg Jun 2021 · Exp Nov 2022 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Jan 2022 |
| Ofloxacin and Ornidazole Tablets I.P. | Batch TI0005AMfg Sep 2020 · Exp Aug 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.